TAO Synergies is headquartered in New York, New York.
TAO Synergies disclosed revenue of 8M USD for 2023 and 16M USD for 2022.
TAO Synergies has 4 employees.
TAO Synergies is a life science company.
TAO Synergies was founded in 2012.
1185 Avenue of the Americas, 3rd Floor ,
New York, New York
10036
United States,
(973) 242-0005
www.taosynergies.com
TAO Synergies is a clinical-stage biopharmaceutical company that has historically worked to develop novel therapies for neurodegenerative diseases. The company has conducted clinical and preclinical studies of its lead therapeutic candidate, Bryostatin-1, in Alzheimer's disease. Preclinical studies have also demonstrated bryostatin's regenerative mechanisms of action for the rare disease Fragile X syndrome, and for other neurodegenerative disorders such as multiple sclerosis, stroke, and traumatic brain injury. TAO Synergies was founded in 2012 and is based in New York, New York.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.2/yr) | # | - | - | - | 1 | - | - | 1 |
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 1 | ||||||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
